Detail akcie Biotage online

Business Summary: Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Biotage AB revenues increased 19% to SEK1.86B. Net income decreased 8% to SEK246M. Revenues reflect EMEA segment increase of 89% to SEK744M, Americas segment increase of 13% to SEK748M. Net income was offset by Distribution costs increase of 18% to SEK403M (expense), Administrative expenses - Balancing valu increase of 30% to SEK161M (expense). Dividend per share remained flat at SEK1.60.